Anti-Tac (daclizumab, Zenapax) in the Treatment of Leukemia, Autoimmune Diseases, and in the Prevention of Allograft Rejection: A 25-Year Personal Odyssey

By Waldmann Thomas  

Journal of Clinical Immunology, Vol. 27, Iss. 1, 2007-01 ,pp. : 1-18

Springer Publishing Company

Access to resources Recommend Favorite

BTI-322 For Acute Rejection After Renal Transplantation

By Mourad M.   Besse T.   Malaise J.   Baldi A.   Latinne D.   Bazin H.   Pirson Y.   Hope J.   Squifflet J.-P.  

Transplantation Proceedings, Vol. 29, Iss. 5, 1997-08 ,pp. : 2353-2353

Elsevier

Access to resources Recommend Favorite

Successful therapy of acute vascular rejection with combined plasma-exchange and monoclonal antibody

By Gupta R.K.   Nampoory M.R.N.   Johny K.V.   Costandi J.N.   Nair M.P.   Francis I.   Ninan V.T.  

Transplantation Proceedings, Vol. 33, Iss. 5, 2001-08 ,pp. : 2770-2773

Elsevier

Access to resources Recommend Favorite

Basiliximab in the therapy of acute rejection after organ transplantation

By Chariat M.N.   Erren M.   Chariat M.   Deng M.   Wolters H.H.   Dietl K.H.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2380-2380

Elsevier

Access to resources Recommend Favorite

Acute rejection after renal transplantation with tacrolimus-based therapy in conditions of normal clinical practice

By Scolari M.P.   Citterio F.   Baldan N.   Rigotti P.   Castagneto M.   Stefoni S.   Segoloni G.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1671-1672

Elsevier

Access to resources Recommend Favorite